BIO vs CTRE · rev $651.0M vs P/E 33, rev $304.1M
BIO (BIO) versus CareTrust REIT Inc. (CTRE) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
CareTrust REIT Inc. (CTRE) is a reit - healthcare facilities company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported CTRE revenue for 2026-06-30 was $304.1M. Net income was $169.2M. CTRE currently screens at market cap $5.86B and trailing P/E 32.9.
BIO currently screens at market cap $0. CTRE currently screens at market cap $5.86B and trailing P/E 32.9.
Not investment advice. Open the BIO and CTRE stock pages for the full models.
Not investment advice.